Antibody

Antibody News

US authorises new antibody drug bebtelovimab to fight Omicron
Health

US authorises new antibody drug bebtelovimab to fight Omicron

The Food and Drug Administration said it cleared the Eli Lilly drug for adults and adolescent patients with mild-to-moderate cases of COVID-19 that also works against the emerging BA.2 mutation of Omicron

All you need to know about various diagnostic tools for COVID-19, Dengue and Zika virus
India

All you need to know about various diagnostic tools for COVID-19, Dengue and Zika virus

With the opening of several new laboratories undertaking these tests since the eruption of Covid, the cost and report-generation time for the examinations have come down considerably

UK study claims COVID-19 immunity may not last over three months; newness of disease causing a paucity of data
Health

UK study claims COVID-19 immunity may not last over three months; newness of disease causing a paucity of data

The study included about 65 confirmed patients of the novel coronavirus infection and 31 health care workers who showed antibodies against the virus.

Bacteria-eating viruses Bacteriophages might help form antibodies, reduce mortality rate due to COVID-19 infection
Health

Bacteria-eating viruses Bacteriophages might help form antibodies, reduce mortality rate due to COVID-19 infection

According to scientists, secondary bacterial infections in the respiratory system, along with delayed production of antibodies, is one of the major reasons for increased mortality rate in COVID-19 patients, especially the elderly ones.

COVID-19 immunity: Studies show antibodies against novel coronavirus may last only for two-six months
Health

COVID-19 immunity: Studies show antibodies against novel coronavirus may last only for two-six months

Nearly 8.5 million people have been reported to be COVID-19 positive in the world and over 456,000 have died of the disease within the past six months.

Lilly's COVID-19 drug, specifically designed to treat the virus, could be authorized for use by September
science

Lilly's COVID-19 drug, specifically designed to treat the virus, could be authorized for use by September

A monoclonal antibody drug developed against COVID-19 is likely to be more effective than repurposed medicines currently being tested against the virus.

Anti-HIV antibody shows promise in first human trial
Life

Anti-HIV antibody shows promise in first human trial

A new anti-HIV (human immunodeficiency virus) antibody has been found safe and controlling HIV levels for about a month in early human trail,